AI-assisted, human-published
03/04/2025 /Funding Events
Nervonik Secures $13M Series A Funding for Opioid-Free Pain Relief Technology
Nervonik, Inc. secures a $13 million Series A funding round led by U.S. Venture Partners (USVP) to advance their opioid-free peripheral nerve stimulation (PNS) system for chronic pain treatment.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com